277 related articles for article (PubMed ID: 21981027)
21. Development and validation of multiplex real-time PCR assays for rapid detection of cytomegalovirus, Epstein-Barr virus, and polyomavirus BK in whole blood from transplant candidates.
Hwang KA; Ahn JH; Nam JH
J Microbiol; 2018 Aug; 56(8):593-599. PubMed ID: 30047089
[TBL] [Abstract][Full Text] [Related]
22. [Clinical Study of Allogeneic Hematopoietic Stem Cell Transplantation Patients with Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus].
Wang ZW; Liu Q; Sun HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):561-567. PubMed ID: 38660867
[TBL] [Abstract][Full Text] [Related]
23. Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients.
Sun HY; Cacciarelli TV; Wagener MM; Singh N
Transpl Immunol; 2010 Aug; 23(4):166-9. PubMed ID: 20609386
[TBL] [Abstract][Full Text] [Related]
24. Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients.
Petrisli E; Chiereghin A; Gabrielli L; Zanfi C; Lauro A; Piccirilli G; Baccolini F; Altimari A; Bagni A; Cescon M; Pinna AD; Landini MP; Lazzarotto T
Transplant Proc; 2010; 42(1):74-8. PubMed ID: 20172284
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
26. Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences.
Bamoulid J; Courivaud C; Coaquette A; Chalopin JM; Gaiffe E; Saas P; Ducloux D
Am J Transplant; 2013 Mar; 13(3):656-62. PubMed ID: 23331474
[TBL] [Abstract][Full Text] [Related]
27. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus].
Song T; Chen G; Zhang X; Xu Y; Chen J; Wang Y; Ye L; Xu J; Wu D; Miao J
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3135-9. PubMed ID: 25573307
[TBL] [Abstract][Full Text] [Related]
28. [Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime].
Gómez E; Melón S; Fresno MF; Tricas L; Navascués R; de Oña M; Herreros M; Alvarez Grande J
Nefrologia; 2002; 22(6):574-81. PubMed ID: 12516292
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Whole Blood and Plasma for Monitoring Cytomegalovirus and Epstein-Barr Virus.
Fukuda Y; Torii Y; Iwata KI; Haruta K; Yamaguchi M; Suzuki T; Narita A; Muramatsu H; Ogura Y; Takahashi Y; Ito Y; Kawada JI
New Microbiol; 2024 May; 47(1):52-59. PubMed ID: 38700884
[TBL] [Abstract][Full Text] [Related]
30. Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients.
Kruger RM; Paranjothi S; Storch GA; Lynch JP; Trulock EP
J Heart Lung Transplant; 2003 Jul; 22(7):754-63. PubMed ID: 12873543
[TBL] [Abstract][Full Text] [Related]
31. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
[TBL] [Abstract][Full Text] [Related]
32. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
[TBL] [Abstract][Full Text] [Related]
33. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
Kumar D; Patil N; Husain S; Chaparro C; Bhat M; Kim SJ; Humar A
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489256
[TBL] [Abstract][Full Text] [Related]
34. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
Singh N; Winston DJ; Razonable RR; Lyon GM; Silveira FP; Wagener MM; Stevens-Ayers T; Edmison B; Boeckh M; Limaye AP
JAMA; 2020 Apr; 323(14):1378-1387. PubMed ID: 32286644
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus DNA monitoring in serum and whole blood in pediatric liver transplant recipients who do or do not discontinue immunosuppressive therapy.
Kullberg-Lindh C; Saalman R; Olausson M; Herlenius G; Lindh M
Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28039929
[TBL] [Abstract][Full Text] [Related]
36. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
McDiarmid SV; Jordan S; Kim GS; Toyoda M; Goss JA; Vargas JH; Martín MG; Bahar R; Maxfield AL; Ament ME; Busuttil RW
Transplantation; 1998 Dec; 66(12):1604-11. PubMed ID: 9884246
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus-related complications in human hand transplantation.
Schneeberger S; Lucchina S; Lanzetta M; Brandacher G; Bösmüller C; Steurer W; Baldanti F; Dezza C; Margreiter R; Bonatti H
Transplantation; 2005 Aug; 80(4):441-7. PubMed ID: 16123716
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and Risk Factors for Viral Infections in Pediatric Liver Transplant Recipients and Impact on Outcome.
Abdullatif H; Dhawan A; Verma A
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243144
[TBL] [Abstract][Full Text] [Related]
39. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
Loginov R; Höckerstedt K; Lautenschlager I
Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
[TBL] [Abstract][Full Text] [Related]
40. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
